More $KNSC news Kenergy Scientific Inc (KNSC) Addresses

New Post Public Reply Private Reply Replies (1) Message Board
fitzkarz Chicks4Free #23221
More $KNSC news>

Kenergy Scientific Inc (KNSC) Addresses Recent Increased Volume and Share Price Surge.

Toronto, ON / ACCESSWIRE / April 1, 2014 / Kenergy Scientific Inc (KNSC) www.knsc.info (The Company) is providing this update to all of its shareholders, followers and stakeholders regarding the Company current recent increased volume and share price surge.

The Company operates a subsidiary Sparx Business Media. www.sparxbusinessmedia.com The Sparx team brings your vision to life. Our talented and creative in-house team offers a depth of experience, diversity and passion for results. We provide our clients with cutting edge marketing solutions driven by results, offering a roster of services from traditional to cutting edge communications.

The management is of the opinion that its current entry into the marijuana advertising space or a portal that will uniquely service that industry space is the driving force behind this sudden surge. (See news release State of the Union Address March 31 2014) KNSC expects to be in a position to release a preview of the portal as soon as the end of this week or the latest early next week. The launch of the site will follow shortly thereafter. The site will feature current marijuana news advertising space fir people in the industry and many medical uses and applications. The portal has been under development for quite some time and is quite elaborate. The Company currently employs 2 full time web master’s as its CIT and SEO on the portal site alone.

More details will follow on the alliances being formed relationships and ventures as the Company enters this very lucrative marijuana media space. Unlike other competitors KNSC derives revenues from Sparx which makes it profitable and self-sustaining and dispenses the need to seek any sort of financing via traditional or alternative means. KNSC share structure remains undisturbed since March 2013 and the Company has no reason to believe that its share structure will change for the foreseeable future.

More details will follow shortly and on a timely basis.

Find us on https://twitter.com/knsc2

Safe Harbor Statement

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These forward-looking statements are based on the current plans and expectations of management and are subject to a number of uncertainties and risks that could significantly affect the company's current plans and expectations, as well as future results of operations and financial condition. A more extensive listing of risks and factors that may affect the company's business prospects and cause actual results to differ materially from those described in the forward-looking statements can be found in the reports and other documents filed by the company with the Securities and Exchange Commission. The company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

Contact:

Kenergy Scientific, Inc.

Investor Relations

mair@360-office.com

SOURCE: Kenergy Scientific, Inc.


Source: Accesswire (April 1, 2014 - 3:16 PM EDT)

News by QuoteMedia
I'm in it to win it!

NASDAQ DIP and RIP
Here is the best word that describes what i do here.
Intuitive;
means having the ability to understand or know something without any direct evidence or reasoning process.

I was born with it, I'm truly blessed!


Alway's searching for winners'
937206596_images.jpg
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Textile Recycling Industry Expected to Hit $7.26 Billion Catalyst

Updated Category News Views 171

Understanding the Textile Recycling Market Growth The global textile recycling market is experiencing significant transformation fueled by a growing emphasis on sustainability and environmental awareness. With a projected value reaching approximately $7.26 billion, and an expected annual growth rate of 4.9%, the industry reflects changing consumer preferences and global...

Continue Reading
Mobile Infrastructure Secures $100M for Growth and Diversification

Updated Category News Views 168

Mobile Infrastructure Corporation Closes Major Financing Round Mobile Infrastructure Corporation (NASDAQ: BEEP) has successfully completed a significant $100 million Asset-Backed Securitization (ABS) focused on enhancing its financial structure and opening avenues for future growth. This landmark achievement is a testament to the forward-thinking strategies and the robust...

Continue Reading
Navigating the Kiosk Market: Trends and Future Growth Insights

Updated Category News Views 198

Global Kiosk Market Overview As we delve into the dynamic landscape of the kiosk market, projections indicate an impressive growth trajectory. The global kiosk market is set to expand significantly, with expectations to reach a remarkable USD 62.2 billion by the end of the forecast period. The anticipated compound annual growth rate (CAGR) of 12.74% from 2024 to 2031...

Continue Reading
Exploring Wallbridge Mining's New Phase 2 Drilling Initiative

Updated Category News Views 121

Wallbridge Mining Launches Phase 2 Drilling at Martiniere Wallbridge Mining Company Limited (TSX: WM, OTCQB: WLBMF) is excited to announce that it has commenced its second phase of drilling at the fully owned Martiniere gold project. This new drilling campaign aims to build on the positive results from its Phase 1 drilling campaign. Continuing Exploration Efforts The...

Continue Reading
Spirovant Sciences Advances Gene Therapy for Cystic Fibrosis

Updated Category News Views 117

Spirovant Sciences Launches Groundbreaking Gene Therapy Trial Spirovant Sciences, a pioneering clinical-stage gene therapy company, has taken a significant step forward in the battle against cystic fibrosis with the administration of the first dose in their SAAVe Phase 1/2 clinical trial of SP-101 combined with a unique augmenter. The Innovative SP-101 Treatment SP-101 is...

Continue Reading